Arcadia Biosciences, Inc.
RKDA · XNASCIK 1469443fmd_0SB7H64JQCP3XER71X56RJYVT0Manufacturing · BeveragesTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2026, 51 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 4 | 1 | 1 | 8 | 7 | 7 | 4 | 5 | 5 |
| Cost of revenue | 1 | 0 | – | – | 5 | 9 | 6 | 2 | 3 | 3 |
| Net interest income | – | – | – | – | – | (0) | 0 | 1 | 1 | 0 |
| Gross profit | 2 | 4 | – | – | 3 | (2) | 1 | 2 | 2 | 2 |
| Realized investment gains (losses) | – | – | – | – | – | – | – | – | 0 | 1 |
| Research and development | 9 | 7 | 6 | 7 | 8 | 4 | 2 | 0 | 0 | 0 |
| Selling, general and administrative | 12 | 11 | 12 | 14 | 16 | 23 | 15 | 8 | 10 | 7 |
| Total operating expenses | 22 | 18 | 18 | 21 | 21 | – | – | – | – | – |
| Operating income | (19) | (14) | (17) | (19) | (13) | (36) | (14) | (6) | (4) | (3) |
| Interest expense | 1 | 1 | – | 0 | 0 | 0 | – | – | – | – |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 1 | 10 | 0 | 0 | 0 | 2 |
| Income before taxes | (20) | (16) | (13) | (29) | (6) | (16) | (11) | (5) | (4) | (2) |
| Income tax expense | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (20) | (16) | (13) | (29) | (6) | (16) | (11) | (5) | (4) | (2) |
| Net income | (20) | (16) | (13) | (29) | (5) | (15) | (15) | (14) | (7) | (2) |
| Net income to common shareholders | (20) | – | – | – | – | – | – | – | – | – |